OsstemImplant Co Ltd
KOSDAQ:048260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
OsstemImplant Co Ltd's latest stock split occurred on Jul 25, 2023
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, OsstemImplant Co Ltd traded at 188000 per share. Afterward, the share price was about 188000.
The adjusted shares began trading on Jul 25, 2023. This was the only stock split in OsstemImplant Co Ltd's history.
Global
Stock Splits Monitor
OsstemImplant Co Ltd
Glance View
Osstem Implant Co., Ltd., a leading company in the dental implant industry, has carved out a significant niche for itself through innovation and strategic positioning. Founded in South Korea in 1997, it quickly ascended the ranks to become a dominant force in the global market. The company's business model revolves around the research, development, and manufacturing of dental implants and related products, targeting dental professionals and clinics worldwide. Osstem has differentiated itself by heavily investing in research and development, ensuring a steady stream of advanced products that meet the evolving needs of practitioners and patients alike. Their prowess in offering high-quality, cost-effective solutions has allowed the company to expand its presence across various continents, making it a recognized name in the dental healthcare industry. Operating in a highly competitive market, Osstem Implant combines quality manufacturing with robust marketing and educational programs. The firm's revenue streams flow primarily from the sale of its comprehensive dental implant systems and related equipment, supported by a network of training centers that have educated thousands of dental practitioners globally. These educational initiatives not only enhance customer loyalty but also serve to ensure that end-users are adept at utilizing their products effectively. Additionally, by maintaining a keen focus on emerging markets and leveraging strategic partnerships, the company continues to bolster its market share, thereby consolidating its financial health and sustainability. Through a commitment to innovation and quality, Osstem Implant not only thrives in an industry that demands precision but also contributes significantly to advancing dental care solutions worldwide.
CHM
6085
688678
CAOEF